CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+29.24%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$9.46B
AUM Growth
+$9.46B
(+4.8%)
Cap. Flow
+$53.3M
Cap. Flow
% of AUM
0.56%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
907
New
103
Increased
256
Reduced
392
Closed
103
Top Buys
1 |
BPMC
Blueprint Medicines
BPMC
|
$59.9M |
2 |
Merck
MRK
|
$49.9M |
3 |
Danaher
DHR
|
$49.5M |
4 |
JD.com
JD
|
$44.8M |
5 |
Thermo Fisher Scientific
TMO
|
$40.8M |
Top Sells
1 |
Regeneron Pharmaceuticals
REGN
|
$114M |
2 |
Alibaba
BABA
|
$102M |
3 |
Salesforce
CRM
|
$58.9M |
4 |
Bristol-Myers Squibb
BMY
|
$58.4M |
5 |
Vertex Pharmaceuticals
VRTX
|
$52M |
Sector Composition
1 | Healthcare | 34.68% |
2 | Technology | 20.98% |
3 | Consumer Discretionary | 8.92% |
4 | Financials | 8.6% |
5 | Communication Services | 7.47% |